Search

everythinglearnresearchcommunity

for

Search:↓

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Genetic discoveries are key for understanding, diagnosing, and treating inherited hair and nail disorders.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Moderately high prolactin levels do not cause hair loss in women.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Some skin diseases and their treatments can negatively affect male fertility.

A 72-year-old man had severe fatigue, weight loss, and frequent loose stools.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Taking Propecia might lead to the development of cataracts.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.